跳至主要内容
临床试验/NCT04191213
NCT04191213Unknown2 期

Efficacy of Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients : A Randomized, Double-blind, Two-armed Parallel-group, Placebo-controlled Phase II/III Study - Khartoum, Sudan

Al-Neelain University2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年2月15日最近更新:
适应症

试验速览

阶段
2 期
入组人数
100
试验地点
2
主要终点
Total anti oxidant capacity

研究概览

简要总结

To study the efficacy of Gum Arabic as an anti-oxidant, anti-inflammatory and Fetal Hemoglobin-inducing agent among Sickle Cell Disease children. Half of participants will receive Gum Arabic and the other half will receive placebo

详细描述

Polymerized hemoglobin is injurious to the red cell membrane, resulting in oxidative damage in sickle cell disease . Fetal hemoglobin is protective against sickling and its decrease is associated with vaso-occlusive crisis . Gum Arabic is soluble fibers with prebiotic properties. It increased the level of serum butyrate which is short chain fatty acid. The latter proved to serve as fetal hemoglobin inducing agent both in vivo and in vitro study. And also has strong anti-inflammatory properties. So our aim to test whether oral digestion of Gum Arabic will induce fetal hemoglobin among sickle cell pediatric patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Participants, care providers, Investigator and outcome assessor will be masked regarding the type of intervention each group will receive

入排标准

年龄范围
3 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Homozygous for Sickle Cell Disease (SS) as documented by Haemoglobin electrophoresis.
  • Subjects whom medications and dosages had been stable for 2 weeks before study entry.
  • Subjects who have not received blood transfusion or had acute episode related to sickle cell disease in the last two weeks before the start of intervention.

排除标准

  • Patients with history of Gum Arabic allergy. Patients who have ischemic heart disease, liver dysfunction or hepatitis. Pregnant female patients who plan to conceive in the next 4 months and fertile female patients who are not using an effective contraception method.
  • Patients who are currently using Gum Arabic. Patients who are on steroids or chemotherapy.

结局指标

主要结局

Total anti oxidant capacity

时间窗: 12 weeks

Measure increase from the baseline values

Fetal hemoglobin level after 12 weeks

时间窗: 12 weeks

Measure increase from the baseline values

次要结局

  • Anti inflammatory marker C reactive Protein(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lamis Kaddam

Director

Al-Neelain University

研究点 (2)

Loading locations...

相似试验